GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Supriya Lifescience SUPRIYA.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

631.25

-9.28%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹8.28bn

FY2018FY2026

Net income

₹2.09bn

FY2018FY2026

Free cash flow

₹429.9m

FY2018FY2026

Shareholders' equity

₹11.98bn

FY2018FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue₹8.28bn₹6.96bn₹5.70bn₹4.51bn₹5.19bn₹3.85bn₹3.12bn₹2.78bn₹2.13bn
Research and development——₹66.9m₹54.0m₹16.6m₹6.6m₹10.6m₹7.8m₹7.1m
Operating income₹2.77bn₹2.50bn₹1.68bn₹1.25bn₹2.11bn₹1.64bn₹1.05bn₹611.0m₹166.9m
Net income₹2.09bn₹1.88bn₹1.19bn₹898.6m₹1.52bn₹1.24bn₹734.0m₹394.2m₹87.3m
Diluted earnings per share26.0123.3514.8211.1618.8615.3728.734.901.09

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assets₹13.57bn₹11.12bn₹9.21bn₹8.20bn₹7.35bn₹4.46bn₹3.36bn₹2.53bn₹2.45bn
Cash and short-term investments₹788.7m₹791.5m₹749.6m₹1.58bn₹2.25bn₹864.3m₹747.0m₹124.0m₹86.1m
Total liabilities₹1.59bn₹1.16bn₹1.06bn₹1.21bn₹1.19bn₹1.77bn₹1.87bn₹1.59bn₹1.91bn
Debt₹54.4m₹53.8m₹54.9m₹224.7m₹274.1m₹721.9m₹845.2m₹923.7m₹1.30bn
Shareholders' equity₹11.98bn₹9.97bn₹8.15bn₹6.99bn₹6.16bn₹2.69bn₹1.49bn₹937.9m₹546.6m
Shares outstanding80m81m80m80m80m80m26m80m80m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations₹1.95bn₹1.73bn₹1.13bn₹661.9m₹488.0m₹799.3m₹1.16bn₹486.7m₹174.5m
Capital spending−₹1.52bn−₹1.62bn−₹1.46bn−₹1.08bn−₹599.0m−₹482.4m−₹245.3m−₹69.5m−₹49.3m
Free cash flow₹429.9m₹101.9m−₹323.5m−₹422.1m−₹111.0m₹316.9m₹915.4m₹417.3m₹125.2m
Dividends paid−₹80.5m−₹64.4m−₹48.3m−₹48.3m−₹43.9m−₹39.6m−₹176.5m−₹176.5m−₹176.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹1.92bn₹2.77bn₹2.06bn₹2.00bn₹1.45bn₹1.84bn₹1.86bn₹1.66bn
Operating income₹1.08bn₹891.2m₹652.6m₹660.1m₹452.5m₹619.0m₹609.9m₹599.7m
Net income₹240.4m₹742.3m₹496.8m₹504.3m₹347.9m₹503.8m₹467.8m₹461.5m
Diluted earnings per share2.999.236.176.264.326.265.825.74
Cash from operations———₹555.0m————
Capital spending———−₹422.0m————
Free cash flow———₹133.0m————
Total assets—₹13.57bn—₹12.03bn—₹11.12bn—₹10.12bn
Cash and short-term investments₹788.7m₹788.7m₹1.03bn₹1.06bn₹791.5m₹791.5m₹843.1m₹869.6m
Debt—₹2.5m—₹3.0m—₹3.2m—₹2.9m
Shareholders' equity₹11.98bn₹11.98bn₹10.82bn₹10.82bn₹9.97bn₹9.97bn₹9.06bn₹9.06bn

Financial ratios

Data as of 17 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin33.4%35.9%29.4%27.8%40.7%42.7%——
Net margin25.3%27.0%20.9%19.9%29.2%32.1%——
Return on equity17.5%18.9%14.6%12.8%24.7%46.0%——
Return on assets15.4%16.9%12.9%11.0%20.7%27.7%——
Free cash flow yield4.9%4.7%3.7%2.5%1.5%1.8%——
Revenue growth18.9%22.1%26.5%-13.2%34.8%23.7%——
Earnings growth11.3%57.8%32.6%-40.8%22.8%68.4%——
Current ratio4.40x5.32x5.17x4.85x4.99x1.82x——
Debt to equity0.00x0.00x0.00x0.02x0.04x0.26x——
Equity ratio88.3%89.6%88.5%85.3%83.8%60.3%——
Interest coverage146.46x148.38x80.85x40.59x50.37x40.30x——
R&D as a share of sales——1.2%1.2%0.3%0.2%0.3%0.3%
Buybacks as a share of market value0.1%-0.2%0.1%0.0%-0.1%-214.7%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue22.4%16.5%—
Operating income30.3%11.0%—
Net income32.5%11.1%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Price to earnings33.832.349.928.212.531.4
Price to sales8.58.710.45.63.610.1

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 4 Sept 2026.

FY2027FY2026FY2025FY2024FY2023
Paid in the year1.001.000.800.600.60

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.